Dexcom (DXCM) Other Non-Current Liabilities (2010 - 2026)

Dexcom (DXCM) has 17 years of Other Non-Current Liabilities data on file, last reported at $141.8 million in Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities fell 5.66% year-over-year to $141.8 million in Q1 2026; TTM through Mar 2026 was $141.8 million, a 5.66% decrease from a year earlier, with the FY2025 full-year figure at $137.1 million, down 7.3% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $141.8 million, up from $137.1 million in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for DXCM reached as high as $151.6 million in Q2 2025 and fell as low as $97.1 million in Q1 2022.
• Historically, Other Non-Current Liabilities has averaged $131.4 million across 5 years, with a median of $129.7 million in 2023.
• Across the five-year window, Other Non-Current Liabilities jumped 42.56% in 2022 and dropped 7.3% in 2025, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $128.3 million in 2022, then dropped by 2.1% to $125.6 million in 2023, then grew by 17.75% to $147.9 million in 2024, then declined by 7.3% to $137.1 million in 2025, then rose by 3.43% to $141.8 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $141.8 million in Q1 2026, $137.1 million in Q4 2025, and $147.4 million in Q3 2025.